+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ISHITADR ISHITADR

Ishita Drugs & Industries Share Price

₹76.20 +2.2 (2.97%)

01 Oct, 2026 4:01 PM (IST)

Ishita Drugs & Industries live price: ₹76.20. It opened at ₹75 vs previous close ₹74; intraday high/low: ₹76/₹71. The 50 & 200 DMA stand at ₹73.60/₹74.90.

Ishita Drugs & Industries Performance

  • Today's Low
  • ₹71
  • Today's High
  • ₹76
  • 52 Week Low
  • ₹66
  • 52 Week High
  • ₹91
  • Open Price₹75
  • Previous Close₹74
  • Volume17,060
  • 50 DMA₹73.60
  • 100 DMA₹74.30
  • 200 DMA₹74.90

Ishita Drugs & Industries Chart

Investment Returns

  • Over 1 Month + 7.51%
  • Over 3 Month + 4.24%
  • Over 6 Month -4.45%
  • Over 1 Year + 0.04%

Smart Investing Starts Here Start SIP with Ishita Drugs & Industries for Steady Growth!

Invest Now

Ishita Drugs & Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 32.3
  • PEG Ratio
  • -1
  • Market Cap Cr
  • 23
  • P/B Ratio
  • 1.9
  • Average True Range
  • 2.3
  • EPS
  • 2.4
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.2
  • RSI
  • 58.52
  • MFI
  • 91.49

Latest Stock News Updates

Ishita Drugs & Industries Ltd - 524400 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Proceedings of the 33rd Annual General Meeting of the Company held on 30th September, 2026 at 11:30 A.M. and concluded on 12:30 P.M.

Ishita Drugs & Industries Ltd - 524400 - Closure of Trading Window

The trading window for dealing in securities of the company by designated persons stands closed from Thursday, 01st Octomber, 2026 till 48 hours after the declaration of the Unaudited Financial statements for the quarter ended 30th September, 2026.

Ishita Drugs & Industries Ltd - 524400 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Availing Credit Facilities From Bank

Pursuant to the Regulation 30read with Schedule III of SEBI(LODR) Regulations, 2015, we wish to inform you that Ishita Drugs and Industries Limited has entred into loan agreement with HDFC Bank Limited.

Ishita Drugs & Industries Financials

Ishita Drugs & Industries Technicals

EMA & SMA

Current Price
₹76.20
+ 2.2 (2.97%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹73.20
  • 50 Day
  • ₹73.60
  • 100 Day
  • ₹74.30
  • 200 Day
  • ₹74.90

Resistance and Support

74.47 Pivot Speed
  • R3 83.10
  • R2 79.70
  • R1 77.90
  • S1 72.70
  • S2 69.30
  • S3 67.50

Ishita Drugs & Industries Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-22 To consider raising of funds
2026-08-08 Quarterly Results
2026-05-30 Audited Results
2026-02-07 Quarterly Results
2025-11-11 Quarterly Results

Ishita Drugs & Industries Shareholding Pattern

50.04%
49.96%
0%

About Ishita Drugs & Industries

Ishita Drugs & Industries is engaged in the business of manufacturing of various APIs (Active Pharma Ingredients) and drug intermediates. It has built up a reputation as a manufacturer of “high quality” products and is known for its ethical dealings in business. The company supplies its products to leading pharmaceutical companies of India. The products are also being exported to various countries across the world. View More
  • NSE Symbol
  • ISHITADR
  • BSE Symbol
  • 524400
  • ISIN
  • INE806D01016

Similar Stocks to Ishita Drugs & Industries

Ishita Drugs & Industries FAQs

Ishita Drugs & Industries share price is ₹76 As on 05 October, 2026 | 04:58

The Market Cap of Ishita Drugs & Industries is ₹22.8 Cr As on 05 October, 2026 | 04:58

The P/E ratio of Ishita Drugs & Industries is 32.3 As on 05 October, 2026 | 04:58

The PB ratio of Ishita Drugs & Industries is 1.9 As on 05 October, 2026 | 04:58

The 52 week High & Low of Ishita Drugs & Industries is ₹90.8/₹66 respectively As on 05 October, 2026 | 04:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23